ABSTRACT ␤-Adrenergic receptor induces cAMP/Protein kinase A (PKA) activation to regulate cardiac contraction. Using real-time fluorescence resonance energy transfer imaging for highly sensitive detection of cAMP and PKA activities, we show two distinct phases in isoproterenol dose-dependent responses in cardiomyocytes: a transient and dose-dependent increase in cAMP and PKA activities at lower concentrations from 10 Ϫ12 to 10 Ϫ8 M; and a saturated initial increases at higher concentrations from 10 Ϫ8 to 10 Ϫ5 M followed by a rapid decrease to different levels that were later sustained in a dose-dependent manner. The dose-dependent temporal responses are patterned by equilibrium between receptor-activated adenylyl cyclase (AC) and phosphodiesterase (PDE). At lower concentrations, cAMP is produced in an agonist dose-dependent manner with AC as a rate-limiting factor. However, the cAMP activities are confined within local domains for phosphorylation of PDE isoforms in the receptor complex but not for phosphorylation of phospholamban and troponin I. At higher concentrations, isoproterenol promotes a dose-dependent selective dissociation of PDE4D but not ACVI from the receptor complex, which shifts the equilibrium between AC and PDE. This shifted balance leads to sustained cAMP accumulation and diffusion for PKA phosphorylation of phospholamban and troponin I, and for myocyte contraction. Pharmacological inhibition or overexpression of either ACVI or PDE4D8 disrupts the balance and shapes the temporal responses in cAMP accumulation. Together, our data reveal a new paradigm for adrenergic agonist dose-dependent cAMP/PKA activities for substrate-specific phosphorylation dictated by dual regulation of AC and PDE in cardiomyocytes.
Introduction
Activation of adrenergic receptors (ARs) represents the primary mechanism to increase cardiac performance under stress. Activated ARs couple to G s proteins, which leads to AC-dependent increases in secondary-messenger cAMP to activate PKA (Lefkowitz, 2007) . The increased PKA activities promote phosphorylation of diversified substrates ranging from the receptor and its associated partners, to ryanodine receptor, phospholamban (PLB), and contractile myofibril proteins such as troponin I (TnI) and troponin T, which eventually leads to increases in contractility and heart rate (Xiang and Kobilka, 2003; Xiao et al., 2006) . Although cAMP/ PKA activation plays an essential role in controlling physiological responses, accumulating evidence indicates that changes in cAMP/PKA activities exert distinct cellular effects via substrate-specificity in highly differentiated cardiomyocytes. For example, ␤ 2 AR displays a high sensitivity to PKA phosphorylation under stimulation with subnanomolar concentrations of isoproterenol in human embryonic kidney (HEK) 293 cells and mouse neonatal cardiomyocytes (Tran et al., 2004; Liu et al., 2009) . In contrast, a minimal concentration of 1 nM isoproterenol is required to promote increases in myocyte contraction rate and contractility .
The concept of spatiotemporal regulation of cellular cAMP and PKA activities provides new insights into understanding how cAMP/PKA signaling is translated into physiological contraction response in highly organized muscle cells (Coo-per, 2005; Zaccolo, 2006) . PKA is anchored on distinct subcellular structures through a family of proteins named A-kinase anchoring proteins. In contrast, correlating to the distribution of most ACs, cellular cAMP is primarily confined along the plasma membrane under neurohormonal stimulation (Cooper, 2005) . Despite being a diffusible small molecule, the distribution and diffusion of cAMP is rather limited because of cAMP degradation mediated by phosphodiesterases (PDEs) (Mongillo and Zaccolo, 2006; Zaccolo, 2006; Houslay et al., 2007) . Under a specific hormonal stimulation, individual PKAs anchored at different subcellular compartments will be selectively activated to conduct the phosphorylation of local proteins for specific cellular processes (McConnachie et al., 2006; Jarnaess and Taskén, 2007) . A spatial distribution of cAMP/PKA signaling regulated by ACs and PDEs is therefore essential for selective phosphorylation of substrates for myocyte contraction.
Consistent with this notion, PDE 4D (PDE4D) has been shown to be significant in regulating the adrenergic receptor subtype-induced myocyte contraction rate response (Xiang et al., 2005) . Recent evidence indicates that PDE4D splicing isoforms selectively bind ␤-adrenergic receptors Richter et al., 2008) . Specifically, PDE4D8 binds to ␤ 1 AR in HEK293 cells and dissociates from the receptor upon stimulation with incremental doses of agonist . In contrast, PDE4D9 and to a lesser extent PDE4D8 bind to ␤ 2 AR in cardiomyocytes ). These receptor-associated PDE4Ds play critical roles in controlling cAMP/PKA activities in the vicinity of the receptors for differential cellular responses under stimulation (Zaccolo and Pozzan, 2002; Xiang et al., 2005; De Arcangelis et al., 2008; Richter et al., 2008) . Inhibition of PDE4 significantly enhances propagation of cAMP/PKA activities for increasing PKA phosphorylation of PLB and myocyte contraction response under low doses of isoproterenol stimulation . This results in saturated responses becoming equivalent to those induced by saturating doses of isoproterenol .
We hypothesized that cardiomyocyte cAMP/PKA signaling is differentially regulated through a balance between AC-dependent cAMP production and PDE-dependent cAMP degradation in an agonist dose-dependent manner. By using high-sensitive fluorescence resonance energy transfer (FRET)-based biosensors for cAMP and PKA activities in living-cell imaging, we found that cAMP/PKA activities displayed two distinct phases in isoproterenol dose-dependent fashion: a transient and dose-dependent increase in FRET ratio at concentration from 10 Ϫ12 to 10 Ϫ8 M, and a saturated initial increase in FRET ratio from 10 Ϫ8 to 10 Ϫ5 M, which was followed by a rapid decrease to different levels that were later sustained in a dosedependent manner. The transient and sustained cAMP/ PKA signals are patterned by a shifting balance between AC-dependent cAMP production and PDE-dependent cAMP degradation at increasing concentration of isoproterenol, which also dictates substrate-specificity for PKA phosphorylation and myocyte contraction responses.
Materials and Methods

Neonatal and Adult Cardiac Myocyte Contraction Assays.
Neonatal and adult myocytes were isolated from newborn or 2-to 4-month-old wild-type FVB mice, respectively. Spontaneously beating neonatal cardiac myocytes were prepared from newly born wildtype or mice lacking ␤ 1 AR or ␤ 2 AR, or both genes as described previously (Devic et al., 2001) . Measurement of spontaneous contraction rate was carried out as described previously (Devic et al., 2001) . Adult myocytes were placed in a dish with HEPES buffer and were electrically stimulated at 30 V/cm at 1 Hz at room temperature. Cell length was recorded with a charge-coupled device camera. Cell contraction shortening was analyzed by Metamorph software (Molecular Devices, Sunnyvale, CA) and normalized as the increase over the basal levels after being fitted to a sigmoidal curve. The maximal shortening was normalized to the baseline value or plotted as a percentage of the maximal response stimulated by 10 M forskolin.
Drug Treatment. Neonatal myocytes were treated with rolipram (10 Ϫ5 M; Calbiochem, San Diego, CA), a PDE4 inhibitor, for 10 min (Alvarez et al., 1995) or with 2Ј,5Ј-dideoxyadenosisne triphosphate (2Ј,5Ј-DDA; 10 Ϫ4 M, Sigma-Aldrich, St. Louis, MO), a selective adenylyl cyclase inhibitor, for 40 min before stimulation. Cells were stimulated with isoproterenol (Iso, 10 Ϫ12 to 10 Ϫ5 M; Sigma-Aldrich) or an AC agonist, forskolin (10 Ϫ5 M; Sigma-Aldrich) .
Immunoprecipitation and Western Blotting. Neonatal cardiac myocytes from wild-type or ␤ 1 ␤ 2 AR gene knockout (KO) pups were infected with recombinant adenovirus expressing HA-tagged mouse ␤ 1 AR, PDE4D8-mCherry, and/or ACVI as indicated. After Iso stimulation for 10 min at different concentrations, cells were rinsed in ice-cold phosphate-buffered saline and lysed in coimmunoprecipitation buffer as described previously . In brief, HA-␤ 1 AR-infected lysates were immunoprecipitated using anti-HA affinity matrix (Roche Diagnostics, Indianapolis, IN). The total immunoprecipitated proteins and 5% of lysates were resolved by 4 to 20% Tris-HCl precast gel (Bio-Rad, Hercules, CA) and plotted with the following antibodies: anti-HA (HA.11; BAbCO, Richmond, CA), anti-ACV/VI (Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-pan PDE4 antibody (Abcam Inc, Cambridge, MA), anti-RFPmCherry (Rockland Immunochemicals, Gilbertsville, PA).
Wild-type neonatal cardiac myocytes were stimulated with Iso for 15 min at different concentration (10 Ϫ5 or 10 Ϫ9 M) as indicated. The lysates were separated by SDS-polyacrylamide gel electrophoresis for Western blotting with antibodies against PLB, phospho-Ser16-PLB (p-PLB), TnI, and phospho-TnI (Badrilla Ltd., Leeds, UK), phospho-(Ser/Thr)-PKA substrate (Cell Signaling Technology, Danvers, MA), and anti ␥-tubulin (Sigma-Aldrich). The primary antibodies were revealed with IRDye 680CW goat-anti mouse or IRDye 800CW goat-anti rabbit secondary antibodies using an Odyssey scanner (LI-COR Biosciences, Lincoln, NE).
Fluorescence Resonance Energy Transfer Recording. Neonatal cardiac myocytes from wild type or ␤ 1 ␤ 2 AR-KO pups were infected with viruses to express either A-kinase activity reporter AKAR3 or cAMP probe ICUE3 as described previously . Living myocytes were imaged on an Axiovert 200M microscope (Carl Zeiss, Thornwood, NY) with a ϫ40/1.3 numerical aperture oil-immersion objective lens and a charge-coupled device camera controlled by a Metafluor software (Molecular Devices). Dual-emission recording of both cyan direct (440/480 nm, excitation/emission) and FRET (440/ 535 nm, excitation/emission) was coordinated by Lambda 10-3 filter shutter controller (Sutter Instrument Company, Novato, CA). Exposure time was 100 ms, and recording interval was 20 s. Images in both channels were subjected to background subtraction, and ratios of yellow-to-cyan color were calculated at different time points. After the PKA phosphorylation on the consensus site in AKAR3, the ratio yellow-to-cyan fluorescent protein displayed increases. However, the binding cAMP to ICUE3 led to decreases in the ratio of yellow-tocyan fluorescent protein , which were plotted with an inverted y-axis.
Statistical Analysis. Curve-fitting and statistical analyses were performed using Prism (GraphPad Software, Inc., San Diego, CA).
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Fig. 1. Activation of ␤ARs induces a dose-dependent increase in cAMP ICUE3 and PKA AKAR3 FRET ratio in cardiomyocyte. A and B, the cAMP biosensor ICUE3 was expressed in wild-type myocytes. Cells were treated with isoproterenol at different concentrations. Changes in cAMP ICUE3 FRET ratio (an indication of cAMP activity) were measured. A, time courses of changes in cAMP FRET ratio were calculated and normalized against the baseline levels. B, the initial peak increases (EC 50 6.86 ϫ 10 Ϫ10 M) and the sustained increases (EC 50 7.99 ϫ 10 Ϫ8 M) in cAMP FRET ratio were plotted. C and D, the PKA biosensor AKAR3 was expressed in wild-type myocytes. Cells were treated with isoproterenol at different concentrations. Changes in PKA AKAR3 FRET ratio (an indication of PKA activity) were calculated and normalized against the baseline levels. C, time courses of changes in PKA FRET ratio were plotted. D, the initial peak increases (EC 50 4.53 ϫ 10 Ϫ10 M) and the sustained increases (EC 50 6.77 ϫ 10 Ϫ8 M) in PKA FRET ratio were plotted. 
Results
FRET-Based Living Cell Imaging Assays Reveal Distinct Feature in Initial and Sustained Responses in cAMP/PKA Activities upon Adrenergic Stimulation in
Cardiac Myocytes. To investigate mechanisms that control the spatiotemporal regulation of cAMP/PKA signaling for substrate phosphorylation and physiological myocyte contraction response, we explored real-time FRET-based living cell-imaging analysis of cAMP and PKA activities. Minimal increases in cAMP and PKA activities were detected at 10 Ϫ10 and 10 Ϫ11 M isoproterenol, respectively (Fig. 1 , A and C), in contrast to a minimal 10 Ϫ9 M isoproterenol required for a detectable increase in myocyte contraction rate . From 10 Ϫ12 to 10 Ϫ8 M, both cAMP and PKA activities displayed a transient and dose-dependent increase in FRET ratio (Fig. 1, A 
and C). From 10
Ϫ8 to 10 Ϫ5 M, the initial peak increases in cAMP and PKA FRET ratios were equivalent but were followed by a rapid decrease to different levels that were later sustained (Fig. 1 , A and C). At the saturating dose of 10 Ϫ5 M, the increase was sustained after reaching peak levels (Fig. 1, A and C) . The EC 50 values of initial peak increases in cAMP and PKA FRET ratio were 6.86 ϫ 10 Ϫ10 and 4.53 ϫ 10 Ϫ10 M, respectively (Fig. 1 , B and D). In contrast, the sustained increases in cAMP/PKA FRET ratio have much higher EC 50 values (7.99 ϫ 10 Ϫ8 M for cAMP and 6.77 ϫ 10 Ϫ8 M for PKA; Fig. 1, B and D) . The EC 50 concentrations for sustained increases are in correlation with the constants of ligand binding (K d ) to ␤ARs or the EC 50 concentrations of the isoproterenol-induced increases in myocyte contraction rate reported previously (Pike and Lefkowitz, 1978; Insel et al., 1983; De Arcangelis et al., 2008) .
Phosphorylation of Phospholamban and Troponin I, and Myocyte Contraction Responses Display Agonist Dose-Dependent Increases upon Adrenergic Stimulation. To understand how the temporal cAMP/PKA signal affects physiological function of cardiac myocytes, we examined PKA phosphorylation of PLB and TnI, and myocyte contraction rate response under stimulation with different doses of isoproterenol. At a saturating dose of 10 Ϫ5 M, both PLB and TnI displayed rapid increases in PKA phosphorylation ( Fig. 2A) . The increases were maintained during 30 min of stimulation ( Fig. 2A) , consistent with the ␤AR-induced sustained increases in cAMP/PKA activities under the same stimulation condition (Fig. 1 , A and C). At peak levels after 10 min of stimulation, the increases in PKA phosphorylation of PLB and TnI displayed an agonist dose-dependent manner (EC 50 , 3.38 ϫ 10 Ϫ8 for PLB and 7.41 ϫ 10 Ϫ9 for TnI; Fig. 2B ), which is consistent with the EC 50 of sustained cAMP/PKA Fig. 3 . Activation of ␤ARs induces a dose-dependent increase in myocyte contraction in both neonatal and adult cardiomyocytes. A, upon isoproterenol stimulation, time courses of changes in spontaneous myocyte contraction rate over baseline level were plotted. The baseline contraction rate (B) and the maximal increase (C, EC 50 4.33 ϫ 10 Ϫ8 M) in contraction rate upon stimulation with isoproterenol were plotted. D, wild-type adult myocytes were paced at 1 Hz and stimulated with forskolin, isoproterenol, norepinephrine, or epinephrine as indicated. The maximal myocyte shortening were normalized against the baseline, and plotted as a percentage of those induced by forskolin. E, the cAMP biosensor ICUE3 was expressed in wild-type adult myocytes. Cells were treated with isoproterenol at different concentrations. Changes in cAMP ICUE3 FRET ratio (an indication of cAMP activity) were calculated and normalized against the baseline levels. F, the initial peak increases (EC 50 7.46 ϫ 10 Ϫ10 M) and the sustained increases (EC 50 9.04 ϫ 10 Ϫ8 M) in cAMP FRET ratio were plotted.
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at ASPET Journals on August 27, 2017 molpharm.aspetjournals.org activities measured by FRET assays (Fig. 1, B and D) . We then carried out neonatal myocyte contraction rate assay; a minimal 10 Ϫ9 M isoproterenol was required for a detectable increase in contraction rate (Fig. 3A) . Whereas the baseline contraction rates were equivalent, upon increasing the concentration of isoproterenol, the contraction rate displayed an agonist dose-dependent increase (EC 50 , 4.33 ϫ 10 Ϫ8 ; Fig. 3 , B and C). The contraction rate response also displays a high correlation with sustained cAMP and PKA activities (Fig. 1) .
We also examined the ␤AR-induced cAMP/PKA activities and contraction responses in more physiologically relevant adult myocytes. In adult myocyte shortening assay, stimulation with isoproterenol, norepinephrine, or epinephrine all induced an agonist dose-dependent increase (Fig. 3D) . At 10 Ϫ9 M isoproterenol and epinephrine, minimal myocyte shortening was detected, whereas at 10 Ϫ9 M norepinephrine, a small but significant myocyte shortening was detected. At 10 Ϫ5 M, all three drugs induced similar maximal shortening in adult myocytes. We then examined cAMP activities in adult myocytes with ICUE3 FRET assay. Stimulation of myocyte with isoproterenol induced a dose-dependent ICUE3 FRET response (Fig. 3E ). Similar to those observed in neonatal myocytes, the responses were transient at submaximal doses but were sustained at the saturated dose. The EC 50 values for initial peak increases and sustained increases were 7.46 ϫ 10 Ϫ10 and 9.04 ϫ 10 Ϫ8 M, respectively (Fig. 3F) . ACs Control the Initial Peak of cAMP/PKA Activities under Adrenergic Stimulation in Cardiomyocytes. To understand the relative contribution of ␤ 1 AR and ␤ 2 AR, the two major subtypes expressed in cardiac myocytes, we used myocytes isolated from mice lacking either ␤ 1 AR or ␤ 2 AR gene (␤ 1 AR-KO and ␤ 2 AR-KO, respectively). Stimulation of endogenous ␤ 1 AR with isoproterenol in ␤ 2 AR-KO myocytes induced responses similar to those in WT myocytes, a transient increase at 10 Ϫ8 M, and a sustained increase at 10 Ϫ5 M isoproterenol, respectively (Supplemental Fig. S1, A and B) . Inhibition of PDE4 with rolipram enhanced the initial peak increases, which also became sustained at both concentrations (Supplemental Fig. S1, A and B) . In contrast, stimulation of endogenous ␤ 2 AR with isoproterenol in ␤ 1 AR-KO myocytes induced smaller and transient responses at both 10 Ϫ8 and 10 Ϫ5 M isoproterenol. Inhibition of PDE4 with rolipram enhanced the initial peak increases, which also became sustained at both concentrations (Supplemental Fig. S1 , C and D). We then aimed to determine the roles of two key components in the system, ACs and PDEs, in controlling the temporal cAMP/PKA activities induced by adrenergic stimulation. ACs have been implicated as a rate-limiting factor in the ␤AR/G s /AC signaling pathway (Ostrom et al., 2000) . Inhibition of AC with 2Ј,5Ј-DDA, a selective AC inhibitor, significantly reduced the cAMP FRET response induced by 10 Ϫ9 M isoproterenol (Fig. 4, A and D) . ACV and ACVI are highly expressed in cardiac muscle cells; overexpression of ACVI alone significantly enhanced the increases of cAMP activity upon stimulation with either minimal 10 Ϫ9 M or saturating 10 Ϫ5 M isoproterenol (Fig. 4, A-D) . Inhibition of PDE4 with rolipram further enhanced the initial peak increases induced by 10 Ϫ9 M isoproterenol (Fig. 4 , A, C, and D). In contrast, overexpression of ␤ 1 AR, the major adrenergic subtype to stimulate cardiac contraction, failed to promote higher initial peak increase in cAMP FRET ratio than those by endogenous ␤ARs in wild-type myocytes (Fig. 4, C and D) . These data suggest that AC is the determining factor for the initial peak increase in cAMP induced by adrenergic stimulation.
PDEs Dissociate with ␤AR and Control the Duration of cAMP/PKA Activities in Cardiomyocytes. In contrast, when the concentration of isoproterenol was increased from the nanomolar to the micromolar range, the ␤AR-induced initial increases in cAMP FRET ratio were saturated (Fig.  1A) . However, these cAMP signals underwent rapid attenuation to different levels, which were later sustained in a dose-dependent fashion (Fig. 1A) . Recent studies show that PDE4D is the major PDE gene that associates with adrenergic stimulation for cardiac myocyte contraction responses (Xiang et al., 2005) , and PDE4D isoforms display preferential association with ␤AR subtypes De Arcangelis et al., 2009 ). In agreement, inhibition of PDE4 with the specific inhibitor rolipram significantly increased both the initial and sustained responses in cAMP FRET ratios induced by 10 Ϫ9 M isoproterenol but was less effective in enhancing the initial and sustained increases in cAMP induced by 10 Ϫ5 M isoproterenol (Fig. 5, A and B) . After inhibition of PDE4, the responses induced by isoproterenol at both doses were equivalent (Fig. 5, C and D) . As a control, inhibition of PDE4 alone did not affect the basal cAMP levels in myocytes (Fig. 5E ). PDE4D can be activated through PKA phosphorylation to act as a negative-feedback mechanism that attenuates cAMP signal upon receptor activation (Alvarez et al., 1995; Baillie et al., 2001 ). Indeed, endogenous PDE4D was phosphorylated by receptor-induced PKA activity at both 10 Ϫ9 and 10 Ϫ5 M isoproterenol (Fig. 6A) . These data support the role of PDE4D activity in shaping the dosedependent sustained increases in cAMP/PKA activities in myocytes.
Because ␤ 1 AR is the major ␤AR subtype responsible for adrenergic stimulation of cardiac contraction, we then examined the association between PDE4D isoforms and ␤ 1 AR upon adrenergic stimulation. Endogenous PDE4D8 bound the ␤ 1 AR in cardiac myocytes at resting state (Fig. 6B) , consistent with the binding of PDE4D8 to ␤ 1 AR in HEK293 cells . Moreover, the PDE4D8/␤ 1 AR complex was stable under stimulation with 10 Ϫ9 M isoproterenol; however, the enzyme was dissociated from the receptor under stimulation with a saturating 10 Ϫ5 M isoproterenol (Fig.  6B) . We also examined the association between individual PDE4D isoforms and ␤ 1 AR upon adrenergic stimulation. 
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PDE4D8, but not a closely related PDE4D9, bound the ␤ 1 AR in cardiac myocytes at resting state but selectively dissociated from the receptor upon stimulation with a saturating 10 Ϫ5 M isoproterenol (Fig. 6C) . Further examination showed that PDE4D8 displayed an agonist-dependent dissociation from the receptor (Fig. 6D) . In contrast, ACVI remained in the receptor complex under stimulation with increasing concentrations of isoproterenol (Fig. 6D) . These data indicate that selective dissociation of PDE4D8 shifts the balance between AC-dependent cAMP production and PDE-dependent cAMP degradation at increasing concentrations of isoproterenol and patterns the agonist dose-dependent temporal responses in cAMP/PKA activities in cardiomyocytes.
We further probed the role of PDE4D8 in shaping the sustained responses induced by ␤AR activation. Overexpression of PDE4D8 completely blocked the increases in cAMP FRET ratio induced by activation of ␤AR at a saturating concentration 10 Ϫ5 M isoproterenol or by activation of ACs with 10 Ϫ5 M forskolin (Fig. 7, A-C) . However, the inhibitory effect of PDE4D8 was readily released by pretreatment with rolipram ( Fig. 7A) or by the addition of rolipram (Fig. 7 , B and C), which promoted the saturated increases in the cAMP FRET ratio. With overexpressed PDE4D8, even activation of overexpressed ␤ 1 AR failed to induce any significant increase in cAMP FRET ratio at 10 Ϫ9 M isoproterenol. However, additional inhibition of PDE4 with rolipram led to the saturated increases in cAMP FRET ratio (Fig. 7D ). In addition, we further dissected the role of individual PDE4D isoforms with overexpression of dominant-negative PDE4Ds containing a mutation destroying catalytic activities. The overexpressed dominant-negative inhibits the endogenous PDE4D isoforms by displacing them from the correct association with receptor complexes. Overexpression of PDE4D8 dominantnegative selectively enhanced the cAMP increase induced by of 10 Ϫ9 M isoproterenol but did not change the transient feature of cAMP response (Fig. 7E) . In contrast, overexpression of dominant-negative PDE4D9, an isoform that does not bind to ␤ 1 AR did not affect the maximal increase in cAMP FRET ratio but slightly delayed the decrease of cAMP FRET responses (Fig. 7E) . These data solidify the functional association of a dominant PDE4D8 activity with the ␤ 1 AR for tuning the cAMP equilibrium upon isoproterenol stimulation in cardiomyocytes.
Discussion
A typical monoexponential dose-dependent cellular response has been a widely accepted pharmacological principle for most G-protein-coupled receptor actions. However, there is lack of correlation between cAMP/PKA activities and myocyte contraction responses under the same stimulation condition (Zhu et al., 2005; De Arcangelis et al., 2008) . In this study, we have used sensitive FRET-based living-cell imaging to analyze cellular cAMP/PKA signals induced by the adrenergic agonist isoproter- Fig. 6 . Agonist dose-dependent dissociations of PDE4D8 but not ACVI from ␤ 1 AR under stimulation of isoproterenol. A, ␤ 2 AR-KO cardiomyocytes were stimulated with isoproterenol at either 10 Ϫ9 or 10 Ϫ5 M for 10 min. The endogenous PDE4 proteins were immunoisolated with anti-PDE antibody, and the isoproterenol-induced PKA phosphorylation of PDE4 proteins was detected in Western blotting. B, ␤ 1 ␤ 2 AR-KO cardiomyocytes expressing HA-␤ 1 AR were stimulated with isoproterenol at either 10 Ϫ9 or 10 Ϫ5 M for 10 min. The endogenous PDE4 proteins were coimmunoprecipitated with anti-HA affinity beads before Western blotting. C, ␤ 1 ␤ 2 AR-KO cardiomyocytes expressing HA-␤ 1 AR together with either PDE4D8-GFP or PDE4D9-GFP were stimulated with either 10 Ϫ9 or 10 Ϫ5 M isoproterenol for 10 min. The receptor-associated PDE4D isoforms were immunoprecipitated with anti-HA affinity beads before Western blotting. D, ␤ 1 ␤ 2 AR-KO cardiomyocytes expressing HA-␤ 1 AR, ACVI, and PDE4D8-RFP were stimulated with isoproterenol at different concentrations for 10 min. The receptor-associated ACVI and PDE4D8 were immunoprecipitated with anti-HA affinity beads before Western blotting. ‫,ء‬ p Ͻ 0.05, and ‫,ءء‬ p Ͻ 0.01 by one-way ANOVA compared with unstimulated controls. enol. Our data indicate that isoproterenol induced two distinct phases in dose-dependent responses in cAMP/PKA activities in cardiac myocytes: a transient and dose-dependent increase of initial response under concentrations from 10 Ϫ12 to 10 Ϫ8 M isoproterenol; and a saturated initial increase under concentration from 10 Ϫ8 to 10 Ϫ5 M isoproterenol followed by a dosedependent decrease to different levels that are later sustained (Figs. 1 and 8) . The sustained but not the initial cAMP/PKA activities display a high correlation to the substrate phosphorylation and myocyte contraction-rate response. Moreover, the agonist dose-dependent temporal increases in cAMP/PKA activities are patterned by a shifting equilibrium between two distinct mechanisms, AC-dependent cAMP production and PDE-dependent cAMP degradation because of the selective dissociation of PDE but not AC from the activated receptor at higher concentrations. This shifting equilibrium allows cAMP accumulation and propagation in cardiomyocytes, which dictates PKA substrate-specificity and cardiac contraction response (Fig. 8) .
Among ␤AR subtypes, the ␤ 1 AR is the major subtype expressed in myocytes and induces stronger cAMP/PKA activities compared with those by the ␤ 2 AR, consistent with our previous studies showing the ␤ 1 AR signaling induces stronger contraction rate responses than that induced by the ␤ 2 AR in cardiac myocytes (Devic et al., 2001) . In addition, a minor role of ␤ 3 AR in negatively controlling cAMP/PKA activities and myocyte con- traction rate has been detected previously (Devic et al., 2001; . However, because of the minimal expression of this subtype in cardiac myocytes, it should have no effect on the cAMP/PKA activities at low doses of isoproterenol and probably a limited effect to modify the cAMP signaling at high doses of isoproterenol. The transient initial increases of cAMP/ PKA activities display a high sensitivity to isoproterenol stimulation at low concentrations, which has a very low EC 50 compared with the binding constants (K d ) (EC 50 is not a binding constant, although it is usually proportional to it) of isoproterenol to ␤ARs (Pike and Lefkowitz, 1978; Insel et al., 1983) . Because receptors are more abundant than G proteins and ACs (Gao et al., 1998; Ostrom et al., 2001) , activation of a small number of receptors may be sufficient in evoking the receptor/ G s /AC system for cAMP production. Thus, the initial peak increases may be a reflection of the available pool of ACs activated in the receptor/G protein/AC system, supporting the notion that the quantity of ACs is the rate-limiting factor in producing cellular cAMP (Gao et al., 1998; Ostrom et al., 2001) . In agreement, overexpression of ACVI, but not ␤ 1 ARs significantly enhances the maximal increases in cAMP accumulation (Fig. 4) .
Alternatively, it has been reported that adrenergic receptors can form precoupled complexes with G s proteins, which display a much higher binding affinity to isoproterenol (Green et al., 1992) . At concentrations from 10 Ϫ12 to 10 Ϫ8 M, the dose-dependent maximal increases of cAMP/PKA activities may be influenced by binding of isoproterenol to the high-affinity sites of the precoupled receptors. In this scenario, the maximal responses are probably due to agonist occupancy at the precoupled receptors, which seems to be sufficient to promote the maximal cAMP production via receptor/G s /AC axis (Figs. 1 and 8) . However, under these low concentrations, the agonist-induced cAMPs are rapidly degraded by the PKA-activated PDE4D within receptor complexes, a negative-feedback mechanism to attenuate cAMP/ PKA signaling (Mongillo et al., 2004; Willoughby et al., 2006; Leroy et al., 2008) . The equilibrium between AC-dependent cAMP production and PDE-dependent cAMP degradation is dominated by the powerful PDE activities, which also functions as a "gating/braking" mechanism to ensure cAMP activities are restricted within the receptor complex or the vicinity for local activation of PKA. Such PKA activation can only have access to the activated receptors (Tran et al., 2004; Liu et al., 2009 ) and receptor-associated downstream signaling components such as PDE4D (Fig. 6A) but not to the substrate in distance, such as phospholamban and troponin I for cardiac contraction.
This scenario is totally different when the concentration of isoproterenol is increased from 10 Ϫ8 to 10 Ϫ5 M. At these concentrations, the AC-mediated cAMP production seems to be maximized. The saturation of cAMP production can be due to many factors, including activation of AC by either G␣ s or G␤␥ subunits inside or outside of caveolae, receptor desensitization, G protein hydrolysis, and negative regulation of AC activities by either kinases or G i proteins (Hanoune and Defer, 2001; Violin et al., 2008; Dessauer, 2009; Sadana and Dessauer, 2009) . In contrast, the receptor-associated PDE4D isoforms display an agonist dose-dependent dissociation from the receptor complex, which results in a shifting equilibrium between AC-dependent cAMP production and PDE-dependent cAMP degradation and promotes sustained increases in cAMP in a dose-dependent manner. The dissociation of PDE4D isoforms also functions as releasing the "gate/brake" to allow propagation of cAMP signal to potentiate PKA phosphorylation of phospholamban and troponin I and cardiac contraction. Perturbation of the balance by altering the expression levels of either AC or PDE or by inhibition of either of them drastically changes the temporal profiles of cAMP activities (Figs. 4, 5, and 7) , dictating the substrate specificity by PKA . Therefore, at higher concentrations, although the AC-dependent cAMP production remains constant within receptor complexes, the dissociation of PDE4D from the receptor seems to open the gate/ release the brake for cAMP diffusion and plays a critical role in shaping the dose-dependent cAMP signaling propagation for myocyte contraction .
Together, using real-time FRET-based biosensors, we have revealed biphasic dose-dependent cAMP and PKA activities under adrenergic stimulation in cardiomyocytes: a transient and dose-dependent increase in initial peak responses at picomolar doses, and saturated initial increases followed by dose-dependent sustained increases at nanomolar doses. These data underscore an elegant integration of dual mechanistic regulation of cAMP/PKA activities by ␤AR-associated AC and PDE in an agonist-dose-dependent manner, which shapes the temporal responses in cAMP/PKA activities for substrate-specificity and physiological myocyte contractionrate responses. Our data provide a new paradigm for further M isoproterenol, the ␤AR-activated AC induces significant production of cAMP (the gas pedal is on), which is transient and restricted at the vicinity of the receptor for local PKA activation. The activated PKA has access to the receptor and receptor-associated PDE that negatively feeds back to confine and attenuate cAMP signaling at local domains (the brake is still on). At 10 Ϫ5 M isoproterenol, the AC-produced cAMP (the gas pedal is on) can propagate to access to PKA in different subcellular compartments because of dissociation of PDE4D from the activated receptors (the brake is off). The activated PKA phosphorylates both local (near the receptor) and distant substrates such as PLB and TnI for myocyte contraction responses. 
